Cytyc Together with Hologic: There's a Certain Logic
What do you get when you cross a women's health company that sells screening and diagnostic imaging technologies to hospitals and radiologists, with a women's health company that sells diagnostics and therapeutic devices to Ob-Gyns? A single company capable of selling goods and services across the entire continuum of care, according to Rob Cascella, president & COO of Hologic, who thus revealed the reasoning behind the $6.5 billion proposed merger of Hologic with Cytyc.
You may also be interested in...
New company Tolero helps MannKind de-risk a preclinical BTK inhibitor program in a “double-jointed” deal in which the “bio-bucks” eventually could flow in either direction.
Brief summaries of recent medtech market and industry developments. This month we cover a new GAO report that ups the pressure on the medical imaging market; Cordis Corp.'s suspension of its PFO closure device program; Atritech's PMA for stroke prevention; Zimmer's acquisition of Abbott Spine; and the US market for contraception devices and procedures.
Intuitive Surgical is the closest thing the health care industry has to Google Inc. With shares trading at or around $300 at publishing time, the robotic surgery pioneer clearly leads the field in a review of five-year and one-year stock valuations of publicly-traded medical device companies conducted by IN VIVO. According to this survey, over the past five years, public investors have shown a strong level of support for the stock of companies with a laser-like focus on a single market area.